The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) protocol

Xun Tang; Yonghua Hu; Dafang Chen; Siyan Zhan; Zongxin Zhang; Huidong Dou
January 2007
BMC Medical Genetics;2007, Vol. 8, p60
Academic Journal
Background: The exact etiology of ischemic stroke remains unclear, because multiple genetic predispositions and environmental risk factors may be involved, and their interactions dictate the complexity. Family-based studies provide unique features in design, while they are currently underrepresented for studies of ischemic stroke in developing countries. The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) program aims to conduct a genetic pedigree study of ischemic stroke in rural communities of China. Methods/Design: The pedigrees of ischemic stroke with clear documentation are recruited by using the proband-initiated contact method, based on the stroke registry in hospital and communities. Blood samples and detailed information of pedigrees are collected through the health care network in the rural area, and prospective follow-up of the pedigrees cohort is scheduled. Complementary strategies of both family-based design and matched case-spousal control design are used, and comprehensive statistical methods will be implemented to ascertain potential complex genetic and environmental factors and their interactions as well. Discussion: This study is complementary to other genetic pedigree studies of ischemic stroke, such as the Siblings With Ischemic Stroke Study (SWISS), which are established in developed countries. We describe the protocol of this family-based genetic epidemiological study that may be used as a new practical guideline and research paradigm in developing countries and facilitate initiatives of stroke study for international collaborations.


Related Articles

  • Lipoprotein(a) and Ischemic Stroke Risk: Who is At Risk? Jamieson, Dara G. // Neurology Alert;Mar2007, Vol. 25 Issue 7, p54 

    Lipoprotein(a) is a low density lipoprotein that is implicated in atherosclerotic cerebrovascular disease. Elevated levels of Lp(a) appear to confer an increased risk of ischemic stroke. However, its variability in different populations leads to uncertainty about the utility of routine screening.

  • Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population. Yan, Jiang-tao; Zhang, Lan; Xu, Yu-jun; Wang, Xiao-jing; Wang, Cong-yi; Wang, Dao-wen // Acta Pharmacologica Sinica;Nov2011, Vol. 32 Issue 11, p1357 

    Aim:To investigate the association of polymorphisms in four critical genes implicated in the NO-forming pathway with ischemic stroke (IS) in a Chinese Han population.Methods:DNA samples of 558 IS patients and 557 healthy controls from Chinese Han population were genotyped using the TaqmanTM...

  • Stroke Risk Gene. Stephenson, Joan // JAMA: Journal of the American Medical Association;4/18/2007, Vol. 297 Issue 15, p1646 

    The article discusses a genetic risk factor of stroke. People with two copies of a genetic mutation in the HFE gene are at a greater risk of developing ischemic cerebrovascular disease and having a stroke than people without the mutation. The mutation, called H63D, brings about an increase in...

  • Ä°skemik Ä°nmede Etyolojik Sınıflandırma. Ay, Hakan // Turkish Journal of Neurology / Turk Noroloji Dergisi;Mar2011, Vol. 17 Issue 1, p1 

    Massachusetts General Hospital, Harvard Medical School, Boston MA, United States of America Ischemic stroke is an etiologically heterogeneous disorder. Classification of ischemic stroke etiology into categories with discrete phenotypic, therapeutic and prognostic features is indispensible to...

  • Achieving Optimum Outcomes in the Treatment of Stroke. Barnett, H.J.M.; Meldrum, H.E. // CNS Drugs;1998 Supplement 1, Vol. 9 Issue 1, p11 

    Treatment for patients with ischaemic stroke is one of the rapidly advancing frontiers in the struggle against disability from brain disease. Transient ischaemic attack and minor stroke have been identified, and the fact that they are a warning of more serious stroke or potentially fatal stroke...

  • Transient Ischaemic Attacks: New Approaches to Management. Madhavan, Ramesh; Chaturvedi, Seemant // CNS Drugs;2003, Vol. 17 Issue 5, p293 

    The fact that transient ischaemic attacks are a harbinger for the possible development of ischaemic stroke has been recognised for several decades. However, within the past decade, our concepts regarding transient ischaemic attacks as a distinct entity from stroke and the prognosis for transient...

  • Mini-Strokes May be More Serious. Palmer, Paul R. // Access;Feb2001, Vol. 15 Issue 2, p10 

    Focuses on ministrokes involving interruptions of blood flow to the brain in San Francisco, California. Consideration of transient ischemic attack (TIA) as warning signs for full stroke; Prevalence of TIA; Reduction of stroke risk after treatment interventions; Accounts on the heightened risk...

  • If I had a transient ischaemic attack at the age of 55. Pearce, J.M.S. // British Medical Journal;4/15/1978, Vol. 1 Issue 6118, p969 

    Discusses what medical options a person should consider in case of a transient ischemic attack (TIA) at the age of 55. Definition of TIA; Aspects of a patient's clinical examination that are included in the assessment of TIA; Causes of TIA; Management of TIA through aspirin and anticoagulants.

  • New treatments, new risk factors for acute ischemic stroke.  // Patient Care;3/30/1999, Vol. 33 Issue 6, p144 

    Focuses on stroke or cerebral vascular disease. Risk factors for acute ischemic attacks; Treatment modalities; Clinical management; Drugs of choice. INSET: Atrial fibrillation: A treatable risk factor..


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics